Senior insider sale
Chief Operating Officer at ZENTALIS PHARMACEUTICALS, INC. — senior position signals high conviction
$190.8K
16.59K shares
What this filing means
BUNKER KEVIN D. plans to sell 16.59K shares of ZENTALIS PHARMACEUTICALS, INC. valued at approximately $190.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/12/2024ACC: 0001725160-24-000049
Officer· Chief Operating Officer
Since Apr 2020
16.59K
Shares to sell
$190.8K
Approx. market value
5.48K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Release
NA
2/10/2024
5.48KTotal acquired5.48K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/10/2024 | Restricted Stock Unit Release NA | 5.48K | — |
| Total | 5.48K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
11.11K
Market value
$128.2K
2/2/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
5.48K
Market value
$62.6K
2/12/2024
Total
Units
16.59K
Value
$190.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/2/2024 | 11.11K | $128.2K | — | Completed |
| Planned — Approximate Date | ||||
2/12/2024 | 5.48K | $62.6K | NASDAQ | Planned |
| Total | 16.59K | $190.8K | ||